CORT
NASDAQ · Pharmaceuticals
Corcept Therapeutics Inc
$33.82
+0.19 (+0.57%)
Performance
1D
—
1W
—
1M
—
3M
-59.08%
6M
-59.68%
1Y
-42.01%
YTD
-11.47%
Open$33.17
Previous Close$33.63
Day High$34.11
Day Low$33.00
52W High$117.33
52W Low$28.66
Volume—
Avg Volume1.71M
Market Cap3.60B
P/E Ratio36.15
EPS$0.83
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$53.13
Below
SMA 200
$69.00
Below
RSI (14)
26
Oversold
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+202.6% upside
Current
$33.82
$33.82
Target
$102.33
$102.33
$62.31
$102.33 avg
$121.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 675.02M | 545.51M | 785.70M |
| Net Income | 88.34M | 64.26M | 178.89M |
| Profit Margin | 13.1% | 12.4% | 22.8% |
| EBITDA | 40.73M | 31.27M | 255.84M |
| Free Cash Flow | — | — | 116.31M |
| Rev Growth | +23.7% | +23.7% | +17.7% |
| Debt/Equity | — | — | 0.15 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |